HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYN


Matt Angel, PhD, on Addressing Unmet Needs in Acute Myeloid Leukemia and Solid Tumors

The chief executive officer and president of Eterna Therapeutics discussed the company’s new collaboration with the University of Texas MD Anderson Cancer Center.

New Data Supports Breyanzi’s Expansion to Chronic Lymphocytic Leukemia

Breyanzi is currently approved for the second-line or later treatment of large B-cell lymphomas.

Around the Helix: Cell and Gene Therapy Company Updates – January 25, 2023

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.